Some physiological and biochemical actions of ergosterol in mammals and birds
Some physiological and biochemical actions of ergosterol in mammals and birds
The development of new fungal food-products which may
contain high levels of ergosterol prompted this investigation into the physiological
and biochemical effects of this compound which may become an increasingly
significant dietary constituent. The level of ergosterol in one new fungal food
product, the R.H.N. mould, was measured and found to be approximately 0.1% dry
weight. There is, however, strong evidence that the level in other moulds may
be as high as 2.5% dry weight.
Ergosterol was tested for rachitogenic properties in the
chick and it was found that it did not inhibit vitamin D under any of the
conditions studied.
The sterol was also tested for hypocholesteraemic actions in
both rats and chicks. No significant lowering of serum or liver cholesterol was
observed when ergosterol was given as a dietary supplement or by subcutaneous
injection in chicks fed normal cereal-based diets. It was also shown that ergosterol
present in great excess did not inhibit the absorption of a single oral dose of
3H-cholesterol in rats or chicks.
Evidence in the literature suggested that ergosterol spares
progesterone in the pregnant, spayed rabbit. This sparing action of ergosterol
on progesterone was demonstrated in the pregnant, spayed rat. Ergosterol was
shown not to have any obvious effects when given orally or subcutaneously at various
stages of pregnancy or in early postnatal life except to increase foetal
mortality when injected into dams in late pregnancy. Ergosterol did not have
any measurable oestrogenic activity in the rat, neither did it alter progesterone
absorption or metabolism. It did, however, possess some measurable oestrogenic
activity in the chick and it also inhibited to a slight extent the oestrogen-induced
hypertrophy of the chick oviduct. Thus ergosterol is weakly anti-oestrogenic in
the chick, note that many anti-oestrogens show some oestrogenic activity when
given in large doses.
It was also found that adrenaline increased the reproductive
performance associated with a given dose of progesterone in ovariectomised rats
but that adrenalectomy in otherwise intact animals resulted in 50% of
pregnancies not continuing in rats.
Although little evidence has been found to suggest that a
high dietary level of ergosterol will have harmful effects, it should be noted
that the rise and scope of this work was limited and much more research needs
to be done before diets containing large amounts of ergosterol are marketed for
human consumption.
University of Southampton
Webb, Geoffrey Paul
b82cdcb0-b096-46e1-8458-c70311e1d709
1974
Webb, Geoffrey Paul
b82cdcb0-b096-46e1-8458-c70311e1d709
Taylor, T.G.
9542b431-59d6-4531-aad0-169c205eedad
Webb, Geoffrey Paul
(1974)
Some physiological and biochemical actions of ergosterol in mammals and birds.
University of Southampton, Doctoral Thesis, 224pp.
Record type:
Thesis
(Doctoral)
Abstract
The development of new fungal food-products which may
contain high levels of ergosterol prompted this investigation into the physiological
and biochemical effects of this compound which may become an increasingly
significant dietary constituent. The level of ergosterol in one new fungal food
product, the R.H.N. mould, was measured and found to be approximately 0.1% dry
weight. There is, however, strong evidence that the level in other moulds may
be as high as 2.5% dry weight.
Ergosterol was tested for rachitogenic properties in the
chick and it was found that it did not inhibit vitamin D under any of the
conditions studied.
The sterol was also tested for hypocholesteraemic actions in
both rats and chicks. No significant lowering of serum or liver cholesterol was
observed when ergosterol was given as a dietary supplement or by subcutaneous
injection in chicks fed normal cereal-based diets. It was also shown that ergosterol
present in great excess did not inhibit the absorption of a single oral dose of
3H-cholesterol in rats or chicks.
Evidence in the literature suggested that ergosterol spares
progesterone in the pregnant, spayed rabbit. This sparing action of ergosterol
on progesterone was demonstrated in the pregnant, spayed rat. Ergosterol was
shown not to have any obvious effects when given orally or subcutaneously at various
stages of pregnancy or in early postnatal life except to increase foetal
mortality when injected into dams in late pregnancy. Ergosterol did not have
any measurable oestrogenic activity in the rat, neither did it alter progesterone
absorption or metabolism. It did, however, possess some measurable oestrogenic
activity in the chick and it also inhibited to a slight extent the oestrogen-induced
hypertrophy of the chick oviduct. Thus ergosterol is weakly anti-oestrogenic in
the chick, note that many anti-oestrogens show some oestrogenic activity when
given in large doses.
It was also found that adrenaline increased the reproductive
performance associated with a given dose of progesterone in ovariectomised rats
but that adrenalectomy in otherwise intact animals resulted in 50% of
pregnancies not continuing in rats.
Although little evidence has been found to suggest that a
high dietary level of ergosterol will have harmful effects, it should be noted
that the rise and scope of this work was limited and much more research needs
to be done before diets containing large amounts of ergosterol are marketed for
human consumption.
Text
Webb 1974 Thesis
- Version of Record
More information
Published date: 1974
Identifiers
Local EPrints ID: 463885
URI: http://eprints.soton.ac.uk/id/eprint/463885
PURE UUID: aa5f4aec-47dd-4b63-adbe-487deac1f70b
Catalogue record
Date deposited: 04 Jul 2022 20:58
Last modified: 30 Sep 2024 11:28
Export record
Contributors
Author:
Geoffrey Paul Webb
Thesis advisor:
T.G. Taylor
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics